Projeto
Smart ruthenium-peptide prodrugs: a ray of hope in the battle against metastatic breast cancer
| Referência: | 2022.00028.CEECIND/CP1722/CT0005 |
|---|---|
| Programa de financiamento: | CEEC IND5ed |
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Universidade Nova de Lisboa |
Registos relacionados
Targeting metastatic breast cancer with innovative ruthenium-peptide conjugates
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
Fighting metastatic cancers: prime time for ruthenium
Fighting metastatic cancers: prime time for ruthenium [PTDC/QUI-QIN/28662/2017]
Targeting cancer with ruthenium compounds
Targeting cancer with ruthenium compounds
Exosomes as drug delivery systems in metastatic breast cancer
Cell-cell communication in metastatic breast cancer: a control point that can lead to breast cancer treatment
Dissect the tumor microenvironment to battle cancer radioresistance and immune escape
Cell-cell direct/indirect communication in metastatic breast cancer as a control point in oncotherapy
Dendrimers and Dendrons Ruthenium-based Nanosystems to tackle Challenging Cancers
HIGH HOPES FOR MIXED COMMUNITIES
Antimicrobial peptides against bacterial pathogens.
Unravelling and modulating the interplay between breast cancer cells and blood-brain barrier endothelial cells: a new hope to prevent brain metastasis formation
Smart hydrogel-based Injectable systems for breast cancer theranostics
Therapeutic deep eutectic systems as promising selective therapeutic agents in the anticancer battle
Broad-spectrum antiviral peptides against respiratory viruses
Development of new prodrugs to manipulate the microbiota of the mammalian gastro-intestinal tract
siRNA incorporation in a lipid/micelle-based nanocarrier as a strategy to restore E-cadherin expression and eradicate advanced breast cancer metastatic phenotype
Development of Peptides for Cancer Diagnostics
Towards the development of antimicrobial peptides active against bacterial biofilms
Engineering fusion inhibitor peptides against childhood respiratory viruses
Development of novel multifunctional nano-polyplexes as imaging and delivery vectors against triple negative breast cancer
GENETIC SUSCEPTIBILITY TO BREAST CANCER
Tetraoxane-based tumor-activated prodrug strategy to target intracellular labile ferrous iron
Non-invasive, innovative and promising strategy for early diagnosis of breast cancer through the establishment of urinary volatile metabolomic profiles of breast cancer patients as well as from breast cancer tissues and breast cancer cell lines
Functionalized magnetoliposomes for enhanced anticancer activity of lactoferrin against triple negative breast cancer cells [2020.05781.BD]
Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication.
Cancer Optical fibers: pre-Metastatic Engineered Tissues [2022.05737.PTDC]
HOPE: HousehOld Particulate mattEr: sources, chemical composition and toxicity.
Rab proteins as novel biomarkers in breast cancer
Towards the development of antimicrobial peptides with antibacterial activity against resistant bacteria and bacterial biofilms
HOPES - HOusing PErspectives and Struggles. Futures of housing movements, policies and dynamics in Lisbon and beyond
A new life for old antimycobacterial drugs: development of prodrugs of pyrazinoic acid activated by mycobacterial esterases as a way to circumvent resistance to pyrazinamide
GRAPHY - Thiol-ene click injectable in situ forming hydrogels incorporating graphene: optimization of the polymer-related features for the immuno-photothermal therapy of metastatic breast cancer [2022.06320.PTDC]
Role of E-selectin ligands in breast cancer metastasis
Doctoral Program MIT Portugal Bio-Engineering Systems Exosomes from Human Mesenchymal Stem/stromal cells for the Delivery of Anticancer Peptides to treat breast cancer
TherMelVac- dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles
MODULATION OF BASE EXCISION REPAIR PATHWAY FOR BREAST CANCER THERAPY
Publicações relacionadas
Carregando publicações...